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Heart developmentenin, is found in both desmosomes and adherens junctions and participates in
Wnt signalling. Mutations in the human gene are implicated in the congenital heart disorder,
arrhythmogenic right ventricular cardiomyopathy (ARVC), but the signalling effects of plakoglobin loss in
ARVC have not been established. Here we report that knockdown of plakoglobin in zebraﬁsh results in
decreased heart size, reduced heartbeat, cardiac oedema, reﬂux of blood between heart chambers and a
twisted tail. Wholemount in situ hybridisation shows reduced expression of the heart markers nkx2.5 at 24
hours post fertilisation (hpf), and cmlc2 and vmhc at 48 hpf, while there is lack of restriction of the valve
markers notch1b and bmp4 at 48 hpf. Wnt target gene expression was examined by semi-quantitative RT-
PCR and found to be increased in morphant embryos indicating that plakoglobin is antagonistic to Wnt
signalling. Co-expression of the Wnt inhibitor, Dkk1, rescues the cardiac phenotype of the plakoglobin
morphant. β-catenin protein expression is increased in morphant embryos as is its colocalisation with E-
cadherin in adherens junctions. Endothelial cells at the atrioventricular boundary of morphant hearts have
an aberrant morphology, indicating problems with valvulogenesis. Morphants also have decreased numbers
of desmosomes and adherens junctions in the intercalated discs. These results establish the zebraﬁsh as a
model for ARVC caused by loss of plakoglobin function and indicate that there are signalling as well as
structural consequences of this loss.
© 2008 Elsevier Inc. All rights reserved.IntroductionPlakoglobin, or gamma-catenin, is a member of the catenin family
of cell adhesion proteins, containing the 42 amino acid armadillo
repeat, the product of the segment polarity gene in Drosophila (Peifer
and Wieschaus, 1990; Peifer et al., 1992, 1994). It is one of only a few
proteins found in both desmosomes and adherens junctions. At the
cell membrane, it associates with the cytoplasmic tail of cadherin
molecules and links them to the actin ﬁlament network in adherens
junctions or to the intermediate ﬁlament network in desmosomes.
The latter are found in tissues that undergo mechanical stress such as
epidermis and heart (for review Garrod and Chidgey, 2008).
In addition to their structural role in cell junctions, cytosolic
plakoglobin and β-catenin participate in canonical Wnt signalling. In
the absence of a Wnt signal, they are phosphorylated and targeted
for degradation by the ubiquitin pathway. Binding of Wnt to a
Frizzled receptor results in stabilisation of the catenin degradation
complex and translocation of the catenin to the nucleus where itARVC, arrhythmogenic right
protein; TCF, T-cell speciﬁc
ly).
l rights reserved.binds to members of the T-cell speciﬁc factor/lymphoid enhancer
factor (TCF/LEF) family of transcription factors (Behrens et al., 1996;
Molenaar et al., 1996). The signalling role of plakoglobin was ﬁrst
indicated when its overexpression in Xenopus resulted in anterior
axis duplication (Karnovsky and Klymkowsky, 1995). However, the
mechanism by which plakoglobin exerts a signalling role is still
uncertain. Studies in keratinocytes have shown that plakoglobin from
adherens junctions can directly move to the nucleus and bind to
transcription factors (Hu et al., 2003). However, in a number of cell
lines, nuclear plakoglobin prevented binding of TCF-4 or LEF-1 to
DNA resulting in a lack of transcriptional activity, whereas studies in
a β-catenin deﬁcient cell line have shown plakoglobin to have direct
TCF/LEF transcriptional activity (Zhurinsky et al., 2000; Miravet et al.,
2002; Maeda et al., 2004). In addition, plakoglobin may also have an
indirect transcriptional activity as a result of replacing β-catenin in
adherens junctions and allowing translocation of β-catenin to the
nucleus (Li et al., 2007).
A mutation leading to the insertion of serine at position 39 in the
N-terminus of plakoglobin causes arrhythmogenic right ventricular
cardiomyopathy (ARVC), which is characterised by irregular heartbeat
and loss of myocardial tissue with replacement by adipose and ﬁbrous
tissue in the right ventricle (Asimaki et al., 2007), whereas a two base
pair (bp) deletion causing truncation of plakoglobin C-terminal results
in Naxos disease, which presents as palmoplantar keratoderma and
woolly hair in addition to the ARVC (McKoy et al., 2000). Mutations in
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et al., 2002; Gerull et al., 2004; Pilichou et al., 2006).
In an effort to model these lethal human diseases, plakoglobin
knockout mice were generated (Bierkamp et al., 1996; Ruiz et al.,
1996). However, they showed embryonic lethality at day E10.5 or E12-
15 due to ruptured ventricles. It is thought that the lack of proper
desmosomes in cardiac tissue prevents it fromwithstanding the onset
of cardiac contraction. In some genetic backgrounds, plakoglobin
knockout mice survived until late gestation but exhibited skin
blistering (Bierkamp et al., 1996). These studies focused only on the
structural role of plakoglobin. Due to this embryonic lethality in mice,
we chose the zebraﬁshmodel system to examine plakoglobin function
because zebraﬁsh embryos can survive for a few days without a
functioning cardiovascular system (reviewed by Stainier, 2001).
Previous studies in zebraﬁsh have identiﬁed zebraﬁsh plakoglobin
and localised the protein expression to cell–cell adhesion junctions in
follicle cells of the ovary (Cerdà et al., 1999). We have previously
localised plakoglobin protein expression in embryos from 1-cell to 72
hours post fertilisation (Martin and Grealy, 2004). We hypothesised
that plakoglobin has a signalling role in addition to its structural role
in embryo development.
Here we report that the loss of plakoglobin results in embryos
with severe cardiac defects. Increased colocalisation of adherens
junction proteins, E-cadherin and β-catenin, in the epithelial layer of
morphant embryos conﬁrms that plakoglobin co-operates with β-
catenin in adhesion. Loss of plakoglobin results in an increase in
Wnt target gene expression indicating that plakoglobin competes
with β-catenin in Wnt/β-catenin signalling. The atrioventricular
endothelial cells of morphant embryos have an abnormal morphol-
ogy indicating aberrant valvulogenesis. Adhesion junctions of the
intercalcated discs in the absence of plakoglobin are lower in
number and have a more diffuse ultrastucture. These results
indicate that plakoglobin has both signalling and structural roles
in zebraﬁsh development.
Materials and methods
Zebraﬁsh maintenance
Zebraﬁsh, AB strain, Tg(ﬂi1:EGFP) and Tg(TOP:GFP)w25 (Lawson
and Weinstein, 2002; Dorksy et al., 2002) were obtained from the
Zebraﬁsh International Resource Centre and maintained under
standard conditions at 28 °C (Westerﬁeld, 1995).
Ampliﬁcation of plakoglobin transcripts
Transcripts of plakoglobin were ampliﬁed from 24 hpf zebraﬁsh
cDNA using primers (Supplementary Data, Table 1) with the following
conditions; 95 °C, 5 min; 95 °C, 60 s; 55 °C, 60 s; 72 °C, 3 min; 35
cycles; 72 °C, 10 min. Products were subcloned in pGEM-TEasy vector
(Promega) and sequenced in the forward and reverse directions by
Agowa Sequencing Service, Germany. The predicted amino acid
sequence was analysed using Predictprotein software (www.predict-
protein.org), and the PSIPRED Protein Structure Prediction Server
(bioinf.cs.ucl.ac.uk/psipred/psiform.html).
Plakoglobin knockdown
A morpholino against the AUG region common to plakoglobin-
1a and plakoglobin-1b was designed by and purchased from Gene
Tools, Oregon (5′-GAGCCTCTCCCATGTGCATTTCCAT-3′). A ﬁve bp
mismatch control morpholino was also used (5′-GACCCTCTGCCA-
TCTGGATTTGCAT-3′). Morpholinos were resuspended in nuclease-
free water at a stock concentration of 1 mM. Plakoglobin morpholino,
control morpholino or phenol red vehicle control (1 nl) was injected at
the 1- to 2-cell stage.Western blotting and immunoprecipitation
Deyolked and dechorionated embryos were collected as described
by Link et al. (2006) with protease inhibitor cocktail (Sigma) in all
solutions. Lysateswere snap frozen in liquid nitrogen, thawed on ice and
50 μl of lysis buffer (400 mM NaCl, 20 mM Tris pH 8.0, 20% Glycerol,
2 mM DTT and 10% protease inhibitor cocktail) were added per 100
embryos. To aid yolk removal, Freon (100 μl)was added to lysateswhich
were vortexed for 30 s and centrifuged at 4°C for 15 min at 11,337×g .
Protein (25 μg) was resolved by 7.5% reducing SDS-PAGE followed by
western blotting. Antibodies used included anti-plakoglobin (1:1000,
BD Transduction Laboratories), anti-α-tubulin (1:2000, Sigma), anti-β-
catenin (1:1000, Sigma), and anti-FLAG antibody (1:2000, Sigma). A
cross-linking anti-mouse IgG antibody (1:2000, Sigma) was used with
the plakoglobin antibody. Secondary antibodies of goat anti-mouse IgG
(1:8000, Sigma) and goat anti-rabbit IgG (1:140,000, Sigma) were used.
The cross-linking anti-mouse IgG antibody and Protein A beads (Sigma)
were used to immunoprecipitate proteins. Following separation by SDS-
PAGE, bands were excised and sequenced by ESI-tandem mass
spectrometry (Dr. S. Liddell, University of Nottingham).
Preparation of mRNA for rescue experiments
Full length open reading frames (ORF) of plakoglobin-1a and
plakoglobin-1b were ampliﬁed using primers that included a FLAG-
tag label at the 5′ end of each construct (Supplementary Data, Table 1).
A second set of primers for each transcript was used to alter 5 bp in the
morpholino target region without altering the resulting protein
sequence using a Quick-change site-directed mutagenesis kit (Strata-
gene). Both constructs were subcloned into pCS2+vector. Capped
mRNA was synthesized using mMessage mRNA kit (Ambion) accord-
ing to manufacturer's instructions.
Wholemount in situ hybridisation (WISH)
Antisense probes were synthesized from linearised plasmid using
SP6, T7 or T3 polymerase and a DIG-labelling RNA kit (Roche).
Embryos were ﬁxed in 4% paraformaldehyde (PFA), dehydrated and
hydrated through a methanol series and hybridized with probe as per
Westerﬁeld (1995) and Hauptmann (1999). The bound probe was
detected with BM-Purple AP-Substrate (Roche).
O-dianisidine staining
Dechorionated embryos were incubated in O-dianisidine staining
solution (2.45mMO-dianisidine, 0.01M sodium acetate, pH 4.5, 0.65%
H2O2, and 40% ethanol) for 15 minutes in the dark at room
temperature. Embryos were ﬁxed in 4% PFA, brieﬂy washed through
a methanol series and mounted for viewing (Ransom et al., 1996).
Immunoﬂuorescence
For sectioning, embryos were embedded in 4% agarose, sectioned by
vibratome and blocked in blocking solution (0.3% Triton X-100, 4% BSA,
PBS). Antibodiesused includedanti-plakoglobin (1:100, BDTransduction
Laboratories), anti-desmocollin 2 and 3 (1:100, Zymed), anti-E-cadherin
(1:100, Sigma), monoclonal anti-β-catenin (1:500, Sigma) and poly-
clonal anti-β-catenin (1:200, Sigma). Isotype-speciﬁc Alexa Fluor-633 or
-546 secondary antibodies were also used (Molecular Probes). Embryos
were examined using Zeiss LSM 510 laser scanning microscope and
colocalisation was quantiﬁed using Zeiss LSM 5 software.
Semi-quantitative RT-PCR
Total RNA from morpholino injected embryos was extracted by
TriReagent (MRC) and was reversed transcribed. The cDNA was used
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(2007). All primer sequences are provided in Supplementary Data,
Table 1.
Transmission electron microscopy (TEM)
Dechorionated embryos at the desired stage were ﬁxed in 2.5%
gluteraldehyde / 2.5% PFA and post ﬁxed in osmium tetraoxide. The
embryos were dehydrated in an ethanol series and embedded in a low
viscosity resin (Agar Scientiﬁc Ltd.). Embryos were sectioned
transversely using a Reichert Jung Ultracut instrument and ultrathin
sections of interest were selected using light microscopy. Ultrathin
sections were stained with uranyl acetate and lead citrate and
examined under a Hitachi H7000 electron microscope.
Statistics
Results were expressed as mean±SD. Normality was tested for
using Shapiro–Wilkes. Differences between groups were evaluated byone way ANOVA and Student–Newman–Keuls. Chi-square tests were
used to compare the distribution pattern of adhesion junctions. A P-
value of less than 0.05 was considered statistically signiﬁcant.
Results
Weused the previously published plakoglobin sequence to amplify
the ORF of zebraﬁsh plakoglobin (Cerdà et al., 1999). However, in
amplifying the ORF and a region of the 3′ untranslated region by PCR,
we obtained two products; one of 2.9 kb, the expected size for
plakoglobin, and a second product of 1.9 kb. Both products were
subcloned and sequenced and these sequences were compared to
Zebraﬁsh ensembl database release 7. Following these sequence
searches, we changed the annotation of the gene previously known as
plakoglobin to plakoglobin-1a. The shorter transcript was annotated
as plakoglobin-1b (GenBank accession no. AM998809). Plakoglobin-
1b shares 99% identity with plakoglobin-1a over the 1248 bp of its
ORF. The plakoglobin-1a transcript contains an additional 1089 bp in
the 3′ end which are absent from the plakoglobin-1b transcript. The
predicted protein product of plakoglobin-1b has an expected
molecular weight of 42 kDa compared to 83 kDa for plakoglobin-1a.
The predicted protein contains only four armadillo repeat domains
compared to 13 repeats for plakoglobin-1a. A comparison of this
transcript variant with the transcripts of armadillo-related proteins in
other species by ClustalW showed plakoglobin-1b to be equally
similar to the human plakoglobin transcript variant 1 and transcript
variant 2 sequences (score 49) (Franke et al., 1989). In Drosophila, two
variants of the armadillo protein have been reported (Peifer and
Weischaus,1990; Loureiro and Peifer,1998). Again, the plakoglobin-1b
transcript is equally similar to the armadillo and the neural armadillo
sequences by ClustalW (score 39).
Phenotype generated by knocking down plakoglobin in zebraﬁsh
To examine the role of plakoglobin in zebraﬁsh,we injected 2.5, 5 or
7.5 ng of plakoglobin morpholino and analysed the phenotypes at 24-,
48-, and 72 hpf (Figs. 1A–F). Embryos were classiﬁed depending on
their phenotype into normal, mild, intermediate or severely affected.
At 24 hpf, mildly affected plakoglobin morpholino injected embryos
had delayed midbrain-hindbrain border formation. Intermediately
affected embryos also had reduced heart size with either oedema or a
kinked tail. Severely affected embryos had all these defects. At 48 hpf
and 72 hpf, mildly affected embryos had kinked tail, oedema and aFig. 1. Effects of plakoglobin knockdown on zebraﬁsh development. (A, C, E) Control
5 bp mismatch morpholino or (B, D, F) plakoglobin morpholino, 5 ng, were injected into
embryos at 1- to 2-cell stage. Phenotypes were observed at (A and B) 24 hpf, (C and D)
48 hpf, and (E and F) 72 hpf. At 24 hpf, (B) morphant embryos displayed oedema
(arrowhead), reduced heart size and a delay in midbrain–hindbrain boundary
formation. At 48 hpf, (D) morphant embryos displayed cardiac oedema, reduced
heart size, kinked tail, blood pooling (asterisk) compared to (C) controls. At 72 hpf, (F)
morphant embryos displayed defects including cardiac oedema, blood pooling and a
kinked tail. The numbers of embryos that displayed the above phenotypes were (A) 120/
129 (B) 111/137 (C) 120/129 (D) 20/137 (E) 120/129 (F) 24/137. (G) Either 2.5 ng, 5 ng, or
7.5 ng, of plakoglobinmorpholinowas injected into embryos at 1- to 2-cell stage and the
phenotypes scored at 24-, 48-, and 72-hpf. The percentage of embryos classed as normal
(blue), mild (maroon), intermediate (yellow), severely affected (light blue) or dead
(purple) for each dose at each timepoint are displayed. At 24 hpf, a similar percentage of
embryos was affected at all doses. However, by 48 hpf, embryos injected with 2.5 ng
appeared normal. 50 embryos were injected per experiment, n=3 separate experi-
ments. (H–K) Lateral views of 72 hpf plakoglobin morphant embryo hearts with
anterior to left and dorsal to top. The cardiac phenotype ranged from a (H) normal
phenotype similar to control injected embryos 49.15%, (I) mildly affected 16.62%, (J)
intermediate 14.61% and (K) severely affected 19.65% morphant embryos alive at 72 hpf
n=129. (L) Western blot analysis of 72 hpf plakoglobin- or control-morpholino injected
embryos, phenol red injected vehicle control and wildtype embryos using anti-
plakoglobin antibody. Plakoglobin was detected in control morpholino injected
embryos, phenol red and wildtype embryos (arrow) but not in morphant embryos
conﬁrming knockdown of the protein by the morpholino. An anti-α-tubulin antibody
was used as a loading control.
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oedema, reduced heart size, blood pooling, reduction in blood
circulation and reﬂux of blood between the chambers of the heart.
Severely affected embryos typically had a complete absence of blood in
a heart that failed to loop. At 24 hpf, at least 90% of embryos were
affected at all doses. However, the majority of embryos receiving the
lowest dose appeared normal by 48 hpf, whereas over 65% of those
receiving the two higher doses remained affected at 48 and 72 hpf (Fig.
1G). A 5 bp mismatch morpholino was injected as a control and at the
2.5 and 5 ng doses these embryos were phenotypically indistinct from
sibling wildtype embryos, whereas 3% of embryos injected with 7.5 ng
of control morpholino showed non-speciﬁc defects at 72 hpf. There-
fore, we chose 5 ng as the dose for further experiments. At this dose,
morphant embryos exhibited a range of cardiac phenotypes, frommild
oedema, to reduced heart size and a failure to loop correctly (Figs. 1H–
K; Supplementary data, videos 1–4). In addition, themean heart rate of
morphants was reduced compared to control morpholino injected
embryos at 48 hpf (106.2±0.58 beats per minute (bpm) vs 117.5±Fig. 2. Plakoglobin-1a RNA rescues the morphant phenotype in a dose-dependent manner. (
was injected on its own (purple) or with 62.5 pg (white), 125 pg (green) or 250 pg (black) of p
affected embryos while co-injection of 62.5 pg of morpholino and plakoglobin-1a resulted in
embryos exhibiting a morphant phenotype. Co-injection of 250 pg of plakoglobin-1a and pla
death. (B) Control morpholino, (C) plakoglobin morpholino, or (D) plakoglobin morpholino a
the (C) morphant phenotype, including cardiac oedema (arrows), was rescued in (D) plako
plakoglobin-1a mRNA was conﬁrmed by western blotting of 24 hpf embryo lysate with an
the expected size of FLAG tagged plakoglobin-1a (arrow). Blotting with an anti-plakoglobin a
of expression in co-injected embryos (arrowhead). An anti-α-tubulin antibody was used as0.91 bpm respectively, Pb0.05). The knockdown of plakoglobin in
morpholino injected embryos was conﬁrmed by western blotting
(Fig. 1L). A band of approximately 83 kDa, the expected size for
zebraﬁsh plakoglobin-1a,was detected in controlmorpholino injected,
phenol red injected and wildtype embryos. No band was detected in
the plakoglobin morphant embryos, indicating that the morpholino
inhibits plakoglobin-1a protein translation. A second band of approxi-
mately 70 kDa was detected with the plakoglobin antibody. This band
was isolated by immunoprecipitation and sequenced bymass spectro-
metry and identiﬁed as vitellogenin-1, an abundant yolk precursor
protein. These results indicate that the morpholino prevents transla-
tion of plakoglobin-1a mRNA resulting in morphant embryos.
The morphant phenotype can be rescued by co-injection of
plakoglobin-1a RNA
To conﬁrm that the observed phenotype was speciﬁc to the loss of
plakoglobin-1a, FLAG-tagged zebraﬁsh plakoglobin-1a mRNA with aA) In each experiment, 5 ng of control morpholino (yellow) or plakoglobin morpholino
lakoglobin-1a RNA. At 72 hpf, injection of plakoglobin morpholino alone resulted in 71%
67% affected embryos. Co-injection of 125 pg of plakoglobin-1a resulted in only 11% of
koglobin morpholino resulted in all embryos showing either an abnormal phenotype or
nd 125 pg of plakoglobin-1a, were injected into embryos at 1- to 2-cell stage. At 72 hpf,
globin morpholino and plakoglobin-1a co-injected embryos. (E) Translation of injected
anti-FLAG antibody. A band of approximately 83 kDa was detected corresponding to
ntibody conﬁrmed knockdown of plakoglobin in morphant embryos and partial rescue
a loading control.
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pholino. A dose response study determined the optimal dose to be
125pgofplakoglobin-1a (Fig. 2A). This dose normalised the plakoglobin
morphant phenotype (Figs. 2B–E) whereas embryos co-injected with
62.5 pg showed themorphant phenotype, while those receiving 250 pg
were severely disrupted or dead. Western blot analysis using an anti-
FLAG antibody detected a band of approximately 83 kDa in co-injected
embryos that was not detected in control morpholino injected or
morphant embryos indicating the translation of the injected plakoglo-
bin-1a (Fig. 2E). These results conﬁrmed that the morphant phenotype
is speciﬁc to the loss of plakoglobin-1a as co-injection of plakoglobin-1a
mRNA with the morpholino resulted in normal embryos.
Plakoglobin-1b cannot compensate for the loss of plakoglobin-1a in
morphant embryos
To investigate the relative contribution of plakoglobin-1b in
zebraﬁsh development a FLAG-tagged plakoglobin-1b construct was
co-injected with the plakoglobin morpholino. The plakoglobin anti-
body could not be used as plakoglobin-1b lacked the antibody epitope.Fig. 3. Plakoglobin-1b RNA fails to rescue morphant phenotype at three doses. (A) Phen
morpholino (purple), co-injection of morpholino and either 62.5 pg of plakoglobin-1b (whit
plakoglobin-1b failed to rescue morphant phenotype at any of the doses injected (Pb0.05,
number of embryos with an abnormal phenotype at 48- and 72-hpf (Pb0.05, vs. morphant).
embryos displayed the morphant phenotype. (D) Co-injection of morpholino and plakoglobi
plakoglobin morpholino, control morpholino or plakoglobin morpholino and plakoglobi
plakoglobin-1b protein (arrow). An anti α-tubulin antibody was used as a loading control.We altered the morpholino binding region to make the plakoglobin-
1b mRNA resistant to the plakoglobin morpholino. This mRNA
(62.5 pg, 125 pg or 250 pg) was co-injected with 5 ng of plakoglobin
morpholino. Co-injection of plakoglobin-1b at any of the doses failed
to rescue the morphant phenotype (Pb0.05 vs. control; Figs. 3A–D).
Plakoglobin-1b injected embryos were subject to western blotting
with an anti-FLAG antibody to detect the protein and conﬁrm the
translation of the injected mRNA. A band of approximately 42 kDa, the
predicted size of plakoglobin-1b, was detected (Fig. 3E). Embryos
co-injected with both plakoglobin morpholino and plakoglobin-1b
RNA were phenotypically morphant indicating that plakoglobin-1b
failed to rescue the effects of plakoglobin knockdown.
Role of plakoglobin in cardiac development
As the cardiac phenotype in morphant embryos was the most
prevalent,weused several cardiacmarker genes to identify the stage at
which cardiac development was perturbed in plakoglobin morphants.
First, we examined cardiac precursor migration and heart tube
formation using nkx2.5, one of the earliest cardiac precursor markersotypic analysis of embryos injected with control morpholino (yellow), plakoglobin
e), 125 pg of plakoglobin-1b (green), or 250 pg of plakoglobin-1b (black). Co-injection of
vs. control). In 125 pg and 250 pg doses, co-injection of plakoglobin-1b increased the
(B) Control injected embryos were unaffected and (C) plakoglobin morpholino injected
n-1b RNA failed to rescue the morphant phenotype. (E) Western blot analysis of 24 hpf
n-1b co-injected embryos. An anti-FLAG antibody was used to detect FLAG-tagged
The presence of FLAG protein conﬁrms plakoglobin-1b was translated.
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morphant embryos at 24 hpf but in the correct location, to the left of
the midline, indicating that the loss of plakoglobin results in fewer
cardiac precursors but does not affect precursor migration or heart
tube formation (Fig. 4B). To investigate heart chamber formation we
examined expression of chamber speciﬁc genes, cardiac myosin light
chain2 (cmlc2) and ventricular myosin heavy chain (vmhc; Yelon et al.,
1999). These were both reduced in 48 hpf morphant embryos
compared to control morpholino injected embryos (Figs. 4C–F).
Expression of these chamber markers also indicated that only the
severely affected morphant hearts failed to loop correctly. The
abnormal reﬂux of blood between the chambers of the heart of
morphant embryos could be as a result of disrupted valve formation.
We examined this using bone morphogenic protein-4 (bmp-4) and
notch 1b. Both genes are expressed throughout the anterior-posterior
axis of the heart prior to 36 hpf and, in normal embryos, expression
becomes restricted to future cardiac valve regions by 37 hpf for bmp4
and 48 hpf for notch1b (Walsh and Stainier, 2001; Westin and Lardelli,
1997). At 30 hpf, expression of notch 1bwas similar to controls in 73% of
plakoglobin morpholino injected embryos (38/52, data not shown). At
48 hpf, notch 1b expression failed to restrict in 79% of morphant
embryos and continued to be expressed throughout the entire heart
(Fig. 4H). Bmp-4 expression at 30 hpf was increased throughout the
embryo in 86% of morphant embryos (49/57, data not shown) and at
48 hpf had failed to restrict to the valve forming regions in 92% of
morphant embryos (Fig. 4J). Therefore, the absence of plakoglobin
results in an increase in bmp-4 and notch1b expression and a loss of the
restriction of these genes that is required for cardiac valve formation.
Cardiac valve morphology is altered in morphant embryos
Following the expanded expression of genes important in cardiac
valve development, we examined cardiac valvemorphology by TEM in
morphant embryos. Using electron microscopy, the structure of 72 hpf
control and morphant hearts was examined. In control hearts, the
cuboidal endothelial cells in the future valve region between the
atrium and ventricle were detected (Figs. 5A and C). However, in
morphant hearts, no cuboidal cells were observed. Instead the
endothelial cells in the area between the atrium and ventricle had
an irregular morphology (Figs. 5B and D). The number of cell junctions
between the endothelial cells in morphants (24 junctions in 33
borders) was reduced compared to control embryos (65 junctions in
34 borders; Pb0.001; see supplementary Table 2). These results
indicate that endothelial cells have an aberrant morphology with
reduced adhesion, indicating abnormal valvulogenesis in the absence
of plakoglobin.
Haematopoiesis and angiogenesis in plakoglobin morphants
Wewished to examine if the reduced circulation and blood pooling
observed in plakoglobin morphant embryos were as a result of
abnormal cardiac function or abnormal haematopoiesis. Firstly, we
conﬁrmed the morphological defects by O-dianisidine staining of
haemoglobin in 48 hpf embryos (Figs. 6A, B). The levels of immatureFig. 4. Expression of cardiac marker genes in plakoglobin morphant and control
morpholino injected embryos. (A and B) lateral views of 24 hpf and (C–J) ventral views
of 48 hpf wholemount embryos. (A) Nkx2.5 at 24 hpf was expressed to the left of the
midline in control injected embryos. (B) Nkx2.5 expression is reduced in morphant
embryos but in the correct location. (C) Cmlc2 is expressed in both atrium and ventricle
in 48 hpf control embryos and there is decreased expression in (D) morphant embryos.
(E) Vmhc delineates ventricle speciﬁcation at 48 hpf and (F) is decreased in morphant
embryos. (G and I) Expression of both notch1b and bmp4 expression was restricted to
the atrio-ventricular boundary (black arrows) in control morpholino injected embryo
hearts. (H and J) In morphant embryos, both cardiac valve markers were expressed
throughout the heart and were not restricted to the atrio-ventricular boundary (white
arrows). The numbers of embryos with the displayed phenotype were (A) 62/65 (B) 55/
63 (C) 72/75 (D) 53/72 (E) 68/70 (F) 40/72,(G) 77/80, (H) 67/85, (I) 74/78 and (J) 68/74.
Fig. 5. The structures of control andmorphant cardiac valves were examined. (A) In control hearts, endothelial cells in the atrioventricular boundary have cuboidal morphology. (B) In
morphant hearts, endothelial cells have a squamous morphology. (C) Higher magniﬁcation of the boxed area in (A). (D) Higher magniﬁcation of the boxed area in (B). Atria are
indicated by (A) and ventricles by (V). The number of embryos with the displayed phenotype were (A) 2/2 and (B) 2/2. Scale bar is 10 μm for A and B and 2 μm for C and D.
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embryos by labelling E-cadherin, which is expressed by developing
erythrocytes (Armeanu et al., 1995). Confocal microscopy of 72 hpf
embryo heart sections showed a reduction in the amount of E-
cadherin-labelled immature blood cells in the morphant heart
compared to control embryos (Figs. 6C, D). To investigate whether
this reduced blood cell expression was due to altered blood
development, we examined expression of the haematopoiesis
markers stem cell leukaemia (scl) and gata1. Stem cell leukaemiaFig. 6. Reduced circulation in morphant embryos. (A, B) Lateral view of O-dianisidine stain
anterior blood vessels, the heart, the common cardinal vein, the dorsal aorta, and posterior ca
vein and there was a reduction in blood cells in the anterior blood vessels. (C, D) Laser-scan
hearts. Fluorescence images with anti-E-cadherin antibody (red), a marker for epithelium and
reduced in (D) morphant heart. Hearts are outlined by white dotted lines. (E–H) The endoth
morpholino were analysed under light (E and F) and ﬂuorescence microscopy (G and H) for
despite evident blood pooling (arrow).encodes a basic helix–loop–helix transcription factor and knockdown
of scl in zebraﬁsh results in a lack of haemangioblasts (Patterson et al.,
2005). The gata 1 transcription factor is downstream of scl and is a
marker for primitive erythoid lineage (Detrich et al., 1995). These
markers for haematopoiesis had normal expression patterns at 20
somites inmorphant embryos (data not shown). This suggests that the
reduction in blood cells was not due to disrupted blood formation. We
next examined if the reduced blood circulation was due to defects in
the vasculature of the morphant embryo. Transgenic ﬂi1:EGFP ﬁshed 48 hpf (A) control and (B) morpholino injected embryos. Blood was present in the
rdinal vein. In themorphant embryo, blood was pooled as it exited the common cardinal
ning immunoﬂuorescence microscopy images of transverse sections of 72 hpf embryo
haematocytes, in (C) control morpholino injected embryo. Haematocyte numbers were
elial speciﬁc transgenic ﬂi1:EGFP embryos injected with (G) control or (H) plakoglobin
vascular defects at 72 hpf. There was no alteration in vasculature in morphant embryos
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to examine angiogenesis. The vasculature was examined at 24 hpf,
48 hpf and 72 hpf. Vascular development was normal in plakoglobin
morphants (Figs. 6E–H). This indicates that any circulation defects or
blood pooling were not as a result of defects in vasculature. From our
study of blood and vasculature formation, we can deduce that
haematopoiesis and angiogenesis are not affected in morphant
embryos but the later abnormal cardiac valve function results in
defects to blood circulation. These results indicate that loss of
plakoglobin results in reduced cardiac chambers with impaired
cardiac valve formation. Although morphants have normal vascula-
ture, these defects result in reduced blood circulation and oedema.
Plakoglobin is antagonistic to Wnt/β-catenin signalling
The increased expression of bmp-4 at 30 hpf indicated that
signalling was altered in morphant embryos. To investigate signallingFig. 7. Loss of plakoglobin increases expression of signalling genes in early stage embryos.
bozozok and (H) sqt compared to their respective control injected embryos (A, C, E and G).
91 (D) 54/87 (E) 50/55 (F) 38/62(G) 61/65 (H) 49/63. (I) Semi-quantitative RT-PCR ampliﬁcat
Lane order: 100 bp ladder, PCR cycle 13,18, 23, 28, 33, positive plasmid control, negative temp
bmp2b and squint were detected ﬁve cycles and bozozok was detected ten cycles earlier in
TOPdGFP ﬁsh. (J) In control morpholino injected ﬁsh, GFP expression is detected at the atr
throughout the heart (white arrowhead). The number of embryoswith the displayed phenoty
morpholino. (L) Control morpholino injected embryos at 72 hpf with normal hearts (165/165)
blood between chambers (88/149). (N) Co-injection of 20 pg of DKK1 and control morpholino
20 pg of Dkk1 and plakoglobin morpholino with normal cardiac phenotypes (10/162).at earlier stages in the morphant embryos we examined the
expression of known Wnt target genes, bozozok and bmp4, and
other signalling pathway components. At the shield stage, bmp-4
expression was increased in 86% of morphant embryos (Fig. 7B).
However, bmp-7 expression was similar in morphant and control
injected embryos (n=57) (data not shown). Bmp2bwas upregulated in
62% of shield stage morphant embryos (Fig. 7D). Wnt/β-catenin
signalling is required for organiser formation in vertebrate embryos.
We examined this using early dorsal markers bozozok (boz) and squint
(sqt) in control-injected and morphant embryos. Bozozok, a home-
odomain protein and direct target of β-catenin, is expressed in the
dorsal yolk syncitial layer and dorsal blastomeres, and co-operates
with squint, a nodal related protein, in organiser formation (Shimizu
et al., 2000 ;Solnica-Krezel and Driever, 2001). Bozozok expression
was increased in 62% and sqt in 78% of sphere stage plakoglobin
morphant embryos (Figs. 7F and H). The relative transcript levels of
bmp-4, bmp-2b, boz and sqt were examined by semi-quantitative RT-Plakoglobin morphant embryos have increased expression of (B) bmp4, (D) bmp2b, (F)
The numbers of embryos with the above phenotype were (A) 49/53 (B) 47/55, (C) 85/
ion from shield and sphere stage plakoglobin and control morpholino injected embryos.
late control and 1 Kb ladder. β-actinwas used as a template control. Expression of bmp4,
morphants than control embryos. Analysis of GFP expression in morpholino injected
ioventricular boundary (black arrowhead). (K) In morphant embryos, GFP is expressed
pewere (J) 31/39 and (K) 34/43. Co-expression study of Dkk1 and control or plakoglobin
. (M) Plakoglobinmorphants at 72 hpf with abnormal hearts including oedema, reﬂux of
resulted in oedema and reﬂux of blood between chambers (30/128). (O) Co-injection of
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embryos. Bmp-4 and bmp-2b appeared at cycle 28 in morphants vs
cycle 33 in controls; boz appeared at cycle 23 in morphants vs cycle 33
in controls and sqt appeared at cycle 23 in morphants vs cycle 28 in
controls (Fig. 7I). The increased expression of Wnt target genes, such
as bozozok and BMP4, in morphant embryos conﬁrms that plakoglobin
is antagonistic to Wnt/β-catenin signalling. To ascertain if this
increase in Wnt/β-catenin signalling in morphant embryos results in
the cardiac phenotype, we examined GFP expression in the TCF
reporter TOPdGFP transgenic line (Dorsky et al., 2002). GFP expression
in control embryos was detected only at the atrioventricularFig. 8. Increased colocalisation of β-catenin and E-cadherin in adherens junctions of plakoglo
of transverse sections of the eye region of 72 hpf embryos. Dual label ﬂuorescence images w
(A–F and J–O) single and as (G–I and P–R) merged images. Images are 400× magniﬁcation. (
and β-catenin. (H) By contrast, in plakoglobin morphant embryos there was extensive colo
plakoglobin-1a co-injected embryos. (R) However, this colocalisation was still evident in p
co-localisation of E-cadherin and β-catenin in control, morphant, plakoglobin morpholino
There was increased colocalisation of the proteins in morphant embryos compared to contr
plakoglobin-1a RNA injected embryos was similar to control injected embryos. (T) In contra
embryos were similar to morphant embryos. Pb0.05. Asterisks indicate statistical signiﬁcanboundary, indicating Wnt/β-catenin activity in these cells (Fig. 7J).
However in morphant embryos, Wnt/β-catenin activity was detected
throughout the heart indicating an increased level ofWnt signalling in
the heart (Fig. 7K). To further examine the relationship of plakoglobin
and Wnt/β-catenin signalling, we co-injected dickkopf-1 (Dkk1), an
inhibitor of Wnt signalling, and examined the resulting phenotype
(Hashimoto et al., 2000). At 24 hpf, 85% (109/128) of embryos co-
injected with control morpholino and Dkk1 displayed the Dkk1
overexpression phenotype of an enlarged head, increased eye size and
shortened body axis, with 17% of embryos also showing somite
defects. While 68% (112/163) of plakoglobin morpholino and Dkk1 co-bin morphant embryos. (A–R) Laser-scanning immunoﬂuorescence microscopy images
ith anti-E-cadherin antibody as red and anti-β-catenin antibody as green are shown as
G) In control morpholino injected embryos, there was little colocalisation of E-cadherin
calisation (yellow). (I) This colocalisation was reduced in plakoglobin morpholino and
lakoglobin morpholino and plakoglobin-1b co-injected embryos. (S) Quantiﬁcation of
and plakoglobin-1a, plakoglobin morpholino and plakoglobin-1b co-injected embryos.
ol morpholino injected embryos. (S) This co-localisation in co-injected morpholino and
st, levels of co-localisation in plakoglobin morpholino and plakoglobin-1b co-injected
ce.
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somite defects. At 72 hpf, control morpholino injected embryos had
normal cardiac phenotype while plakoglobin morpholino injected
embryos displayed the morphant phenotype (Figs. 7L and M). By
72 hpf, 24% of control morpholino and Dkk1 co-injected embryos
exhibited cardiac defects including failure to loop and reﬂux of blood
between chambers (Fig. 7N). However, in plakoglobinmorpholino and
Dkk1 co-injected embryos, only 6% of embryos exhibited cardiac
defects (10/162; Pb0.001 vs plakoglobin morpholino; Fig. 7O). These
results indicate that in the absence of plakoglobin, Wnt/β-catenin
signalling is increased. Co-injection of DKK1 rescues this defect. These
results highlight the importance of the antagonistic signalling role of
plakoglobin in embryo development.
Loss of plakoglobin does not increase β-catenin mRNA expression but
increases protein expression
As Wnt signalling is increased in morphant embryos, we wished
to examine if the loss of plakoglobin resulted in changes in β-
catenin mRNA or protein expression. β-catenin protein expression
was examined by western blotting using an antibody that
recognises both β-catenin-1 and β-catenin-2. Total β-catenin protein
was increased in plakoglobin morphant embryos (Supplementary
Fig. 1A). Protein levels were normalised to α-tubulin. The relative
levels of total β-catenin to α-tubulin in morphant embryos was
147.66±15.67 relative densitometric units compared to 78.10±3.84
relative densitometric units for control injected embryos (Pb0.05,
Supplementary Fig. 1B, n=3). β-catenin mRNA was then examined
to determine if this increase was due to increased transcription or
translation of the β-catenins. β-catenin-1 and β-catenin-2 mRNA
localisation was normal in morphant embryos as examined by WISH
(Supplementary Figs. 1C–F). The relative transcript levels of β-
catenin-1 and β-catenin-2 were examined by semi-quantitative RT-
PCR. β-catenin-1 was ﬁrst detected at cycle 28 in both control and
plakoglobin morphant embryos. β-catenin-2 was ﬁrst detected atFig. 9. Loss of plakoglobin results in fewer adhesion junctions and with an altered structure
72 hpf. (A) In control morpholino injected embryos, desmosomes (black arrowheads) were
detected. (C) A table of indicating the cell–cell borders numbers, the number of adhesion j
Unclassiﬁed indicates adhesion junctions that could not be deﬁnitively classed as adherenscycle 33 in both control and morphant embryos. β-actin was
detected at cycle 23 in both the plakoglobin morphant and control
injected samples. These results show that β-catenin-1 and β-catenin-
2 levels are similar in morphant and control injected embryos
(Supplementary Fig. 1G) indicating that increased expression of β-
catenin in morphant embryos was not due to increased transcrip-
tion but may be due to increased translation or increased stability of
the β-catenin protein.
β-catenin compensates for loss of plakoglobin in adherens junctions but
not in desmosomes
We examined the effect of the loss of plakoglobin and the
increased β-catenin protein expression on the localisation of other
adherens junction proteins by confocal immunoﬂuorescence micro-
scopy. β-catenin and E-cadherin had distinct localisation patterns in
control-injected 72 hpf embryos (Fig. 8G). However, in plakoglobin
morphant embryos these two adhesion proteins were extensively
colocalised (Fig. 8H). Quantiﬁcation of colocalisation, using Pearson's
correlation coefﬁcient, conﬁrmed the increase in co-localisation of E-
cadherin and β-catenin in morphant embryos compared to control
embryos (Pb0.05, Fig. 8S). Embryos co-injected with morpholino and
plakoglobin-1a had a similar level of co-localisation to control
embryos, indicating that co-injecting plakoglobin-1awith morpholino
could rescue the morphant phenotype (Fig. 8I). However, co-injection
of plakoglobin-1b failed to rescue the phenotype and co-localisation
was similar in co-injected plakoglobin-1b and morpholino to mor-
phant embryos (Fig. 8R). Therefore, in the absence of plakoglobin-1a,
β-catenin increased its bindingwith E-cadherin in adherens junctions.
We next examined the effect of loss of plakoglobin on desmosomal
proteins. β-catenin is not normally expressed in desmosomes and
there was little co-localisation of β-catenin and the desmosomal
cadherins, desmocollin 2 and 3 in control injected embryos. In
plakoglobin morphant embryos, there was no change in the expres-
sion pattern of β-catenin or desmocollins 2 and 3 (Supplementary. (A and B) Electron microscopy of the intercalated discs of zebraﬁsh embryo hearts at
in series. (B) In morphant embryos, diffuse adhesion junctions (white arrowhead) were
unctions, and the number of each type of junction in control and morphant embryos.
junction, desmosome or tight junction. N=2 embryos per sample. Scale bar is 100 nm.
93E.D. Martin et al. / Developmental Biology 327 (2009) 83–96Figs. 2A–F). There was no statistical difference in colocalisation of the
proteins in control morpholino and plakoglobin morpholino injected
embryos (Supplementary Fig. 2G). Controls for the desmocollin
antibody are included in Supplementary Fig. 2. These results indicate
that β-catenin compensates for the loss of plakoglobin in adherens
junctions but not in desmosomes in plakoglobin morphant embryos.
Loss of plakoglobin results in reduced and altered adhesion junctions
We next examined the ultrastructure of adhesion junctions in the
intercalated discs of control andmorphant 72 hpf embryos by electron
microscopy. In control embryos, adherens junctions and desmosomes,
with their distinctive dense tripartite composition, could be easily
distinguished and were often observed in a series at the cell borders
(Fig. 9A). However in morphant embryos (Fig. 9B), there was a striking
loss in the number and proportion of adherens junctions and
desmosomes, despite similar numbers of cell–cell borders (pb0.05)
(Fig. 9C). Adhesion junctions, when present, were more diffuse in
structure than either the adherens junctions or desmosomes observed
in control embryos and therefore were difﬁcult to distinguish. These
results indicate that the absence of plakoglobin results in a reduced
number of adhesion junctions.
Discussion
In this study, we have shown that plakoglobin-1a has both
structural and signalling roles in zebraﬁsh embryo development.
Loss of plakoglobin-1a resulted in cardiac oedema, abnormal cardiac
development and abnormal cardiac valve formation. β-catenin
compensated for the loss of plakoglobin in adherens junctions but
not in desmosomes. Loss of plakoglobin resulted in an increase inWnt
signalling in the heart and throughout the embryo.
The absence of plakoglobin in zebraﬁsh resulted in cardiac defects
which are broadly similar to those found when desmocollin-2 was
knocked down in zebraﬁsh (Heuser et al., 2006), or when plakoglobin
was knockeddown inmice (Bierkampet al.,1996; Ruiz et al.,1996). All of
thesemanipulations recapitulateARVC inhumans.Due to theembryonic
lethality of plakoglobin null mice, Kirchhof et al. (2006) studied the
effects of reduced plakoglobin in heterozygous plakoglobin deﬁcient
mice; these mice also had enlarged right ventricles with arrhythmias.
Mutation of plakoglobin in humans also results in arrhythmias and
replacement of ventricle muscle tissue by adipose tissue (McKoy et al.,
2000). In addition, a few plakoglobin knockout mice in some genetic
backgrounds exhibited skin blisters which were not detected in the
zebraﬁsh morphant (Bierkamp et al., 1996, 1999). However, the primary
cardiac phenotype was similar in mice and zebraﬁsh.
We have identiﬁed a transcript variant of plakoglobin in zebraﬁsh,
plakoglobin-1b. Splice variants of the human plakoglobin have been
identiﬁed in carcinoma cell lines (Franke et al.,1989;Ozawa et al.,1995).
However, this second zebraﬁsh transcript was identiﬁed in wild type
embryos. The armadillo protein in Drosophila has an isoform which
functions in differentiating neurons, which may indicate a speciﬁc
tissue expression of plakoglobin-1b at a later stage in embryo
development (Loureiro and Peifer, 1998). As the transcript lacks the
plakoglobin antibody epitope, its protein expression could not be
localised in the embryo. It does not function redundantly with
plakoglobin-1a as co-injection of plakoglobin-1b mRNA with morpho-
lino failed to rescue the morphant phenotype or change the colocalisa-
tion ofβ-catenin and E-cadherin at adherens junctions. Thismay be due
to the structure of the plakoglobin-1b protein. The amino terminal and
ﬁrst armadillo (arm) repeat of the human plakoglobin protein
comprises the α-catenin binding domain. The ﬁrst three armadillo
repeats contain a desmoglein binding domain, while arm repeats 4 and
5 mediate E-cadherin binding (Chitaev et al., 1996; Troyanovsky et al.,
1996). Plakoglobin-1b has these domains but the lack of arm repeats 6–
13 may affect the targeting of the complex to adherens junctions anddesmosomes. The region of arm repeats 6–10 has been identiﬁed as the
minimum required for axis duplication in Xenopus mutation experi-
ments and so indicates that the domain is important in plakoglobin
signalling (Rubenstein et al.,1997). The absence of this domain suggests
that plakoglobin-1b does not play a signalling role in zebraﬁsh. This
protein also lacks desmosomal cadherin binding domains that
modulate the interaction of desmosomal cadherins (Wahl et al., 1996).
The presence of a second immunoreactive band in western immuno-
blotting with the plakoglobin antibody raised the possibility of the
presence of additional transcript variants of plakoglobin-1a as itwasnot
of the predicted size for plakoglobin-1b. However, the band was
identiﬁed as vitellogenin-1, and vitellogeninwas found to contaminate
zebraﬁsh lysates in proteomic analysis of zebraﬁsh proteins (Link et al.,
2006; Tay et al., 2006). The presence of this abundant yolk protein may
hinder the identiﬁcation of plakoglobin isoforms.
Plakoglobin morphant embryos have defective cardiac valves with
increased expression of bmp4 and notch1b. Hurlstone et al. (2003)
proposed a role for Wnt/β-catenin signalling in cardiac valve
development. Loss of adenomatous polyposis coli (APC), a component
of the catenin destruction complex, in zebraﬁsh caused an upregula-
tion of Wnt/β-catenin signalling, resulting in an excess of endocar-
dium. In our study, the loss of plakoglobin also resulted in a loss of
restriction of bmp4 and notch1b, increased Wnt signalling and altered
cardiac valve formation. However we did not observe the excessive
endocardial cushion outgrowth reported by Hurlstone and colleagues.
Instead we found that whereas the endothelial cells of the atrio-
ventricular canal of control embryos were cuboidal in shape,
plakoglobin morphants lacked these cuboidal cells. This is similar to
the ﬁndings of Beis et al. (2005) following ectopic expression of the
Notch intracellular domain in all endothelial cells. These authors also
found that loss of APC increased expression of cuboidal endothelial
cells in the ventricle of APC mutant. They argue that increased notch
signalling maintains squamous endothelial cells and prevents transi-
tion to the cuboidal shape. An alternative possibility is that increased
notch signalling in the plakoglobin morphants caused increased
endothelial to mesenchymal transition, which is characterised by loss
of junctions and altered shape of endothelial cells, both of which were
seen in the plakoglobin morphants. This effect was observed by
Timmerman et al. (2004) in mice with increased Notch signalling.
However, recent studies suggest that in zebraﬁsh endocardial
cushions do not form, but leaﬂets are formed directly by invagination
(Scherz et al., 2008). In the light of this report, it appears that in
plakoglobin morphants endothelial cells fail to transition from a
squamous to a cuboidal shape.
Despite having transcriptional activity through the T-cell speciﬁc
family of transcription factors, plakoglobin does not appear to play a
role in haematopoiesis. Expression of haematopoietic markers scl and
gata 1 appeared normal in morphant embryos. Later defects in
circulation may be as a result of secondary effects due to a non-
functioning cardiovascular system. This agrees with the ﬁndings of
Koch et al. (2008) who showed that the conditional knockout of β-
catenin in plakoglobin knockout mice did not affect haematopoiesis.
Our ﬁndings indicate that the loss of plakoglobin results in an
increase in β-catenin protein expression. Although this is not due to
increased transcription, it may be due to increased translation or an
increase in protein stability due to less degradation via the ubiquitin
pathway. This is in contrast to the ﬁndings in plakoglobin knockout
mice where there was no increase in β-catenin levels in keratinocytes
(Bierkamp et al., 1999). These authors also found that β-catenin
localised to the desmosomes in mice lacking plakoglobin, which we
did not ﬁnd in plakoglobin morphant zebraﬁsh embryos. However, we
found increased colocalisation of β-catenin with E-cadherin, suggest-
ing β-catenin increases its role in adherens junctions to compensate
for the loss of plakoglobin. Similarly, in the absence of β-catenin in
mouse embryos, plakoglobin becomes more co-localised with E-
cadherin (Huelsken et al., 2000). In β-catenin deleted cell lines,
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junctions (Fukunaga et al., 2005). Cardiac speciﬁc deletion of β-
catenin in adult mouse cardiomyocytes resulted in increased
plakoglobin expression at intercalated discs and did not affect any
other adherens junctions proteins (Zhou et al., 2007). These results,
together with the increased co-localisation of β-catenin and E-
cadherin in plakoglobin morphants conﬁrm that β-catenin and
plakoglobin share a function in adhesion junctions. Therefore, β-
catenin can fulﬁl some of roles of plakoglobin in the cell by
compensating for the loss of plakoglobin in adherens junctions.
Morphant embryos showed a striking loss of desmosomes and
adherens junctions compared to control embryos, with a concomitant
increased expression of diffuse junctions, which were not seen in the
controls. These likely represent altered adherens junctions and
desmosomes. These results are in general agreement with ﬁndings
when desmosomal proteins were ablated. In desmocollin-2 zebraﬁsh
morphants, desmosomes were also reduced in number and lacked the
midline structure between the cell–cell membranes (Heuser et al.,
2006). Ultrastructural studies in the plakoglobin knockout mouse also
showed a reduced number of desmosomes with an altered structure
and the absence of the cytoplasmic plaque (Bierkamp et al., 1999).
Another study of the intercalated discs of plakoglobin knockout mice
showed the presence of extended adhesive structures that contained
both desmosomal and adhesion junction components rather than
distinctive desmosomes (Ruiz et al., 1996). These results indicate the
loss of plakoglobin disrupts adhesion junction structure in morphant
embryos.
The absence of plakoglobin results in an increase in Wnt target
gene expression. Bozozok acts downstream of β-catenin and is
required for organiser formation and development of axial mesoderm
(Fekany et al., 1999; Leung et al., 2003). Here we show that, in the
absence of plakoglobin, expression of these genes is increased. The
absence of the characteristic phenotype associated with overexpres-
sion of the genesmay be explained by the negative feedback loop such
as for bozozok (Solnica-Krezel and Driever, 2001). Crosstalk between
signalling pathways is a complex control mechanism for organ
formation. The current study shows that an increase inWnt signalling
resulted in an increase in BMP and Notch signalling pathways. In mice,
a mutation in APC resulted in increased Wnt signalling and also
increased Notch signalling (van Es et al., 2005). Wnt signalling has
been shown to increase BMP-2 signalling resulting in mesenchymal
differentiation (Nakashima et al., 2005). Our study shows that
inhibition of the increase in Wnt signalling in morphant embryos by
co-injectingDkk1 rescued the cardiac phenotype. Studies by Hurlstone
et al. (2003) have shown that inhibition of endogenousWnt/β-catenin
signalling, by Dkk1 overexpression, results in an absence of endo-
cardial cushion formation. Recent studies have uncovered the
importance of Wnt signalling at particular time points in cardiac
development. While previously considered an inhibitor of cardiac
formation, Wnt signalling has been found to have an important pro-
cardiac role (Lickert et al., 2002). Expression of Wnt signalling prior to
gastrulation promoted cardiac differentiation, but was inhibitory to
cardiac formation if expressed after gastrulation, indicating the critical
temporal-speciﬁc expression of Wnt in cardiac formation (Naito et al.,
2006; Ueno et al., 2007). It is likely that the continual upregulation of
Wnt signalling observed in plakoglobin morphant embryos disrupted
this important temporal-speciﬁc expression of Wnt and thereby
altered cardiac formation.
Heuser et al. (2006) have previously used zebraﬁsh with disrupted
desmosomes as a model for ARVC. The failure of plakoglobin to
localise to desmosomes when mutated and when other desmosomal
components are mutated has been proposed to identify a common
mechanism for ARVC (Tsatsopoulou et al., 2006). Garcia-Gras et al.
(2006) have shown that a reduction in Wnt signalling can result in
ﬁbrous and lipid replacement of cardiac tissue similar to ARVC in
cardiac restricted desmoplakin knockout mice. They have proposed amechanism for ARVC in which mutated desmosomal genes result in
the release of plakoglobin from desmosomes and translocation to the
nucleus, suppressingWnt signalling. Loss ofWnt signalling resulted in
myoblasts changing to adipocytes in vitro (Ross et al., 2000). It is
unclear how mutations in plakoglobin itself, which results in ARVC,
could be incorporated into this model. We propose that the loss
of both the structural and the signalling roles of plakoglobin results
in ARVC, and that the signalling defects are due to increased Wnt
signalling.
However, the use of zebraﬁsh as a model system for the study of
ARVC has a number of limitations. The use of morpholinos restricts
examination of phenotype to early developmental stages and
subsequent steps in disease progression, such as replacement of
cardiac tissue with fatty tissue cannot be examined. Another
limitation is the possible presence of a second copy of a gene due to
genome duplication in zebraﬁsh after separation of ﬁsh from the
mammalian lineage. Recent studies have identiﬁed differences in the
structure of adhesion junctions in cardiomyocytes of lower verte-
brates compared to mammals. Fish cardiomyocytes contain discrete
structures of adherens junction components and desmosomal
components compared to the composite junctions detected in higher
vertebrates (Pieperhoff and Franke, 2008). However, formation of
these composite junctions occurs late in mammalian development,
mainly post-natally, and at the stages examined in the current study
separate adherens junctions and desmosomes are present in mam-
malian embryonic hearts similar to those in zebraﬁsh (Pieperhoff and
Franke, 2007). Thus, plakoglobin knockdown in zebraﬁsh provides an
excellent model to investigate the underlying molecular mechanisms
of ARVC.
From this study, we can conclude that plakoglobin co-operates
with β-catenin in adherens junctions but acts antagonistically with it
in Wnt signalling. We have provided evidence for the possible
mechanism of ARVC involving plakoglobin. We identiﬁed both
signalling and structural roles for plakoglobin in zebraﬁsh embryo
development.
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